Form 8-K - Current report:
SEC Accession No. 0001144204-12-035275
Filing Date
2012-06-18
Accepted
2012-06-18 16:57:41
Documents
1
Period of Report
2012-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K v316334_8k.htm 8-K 21896
  Complete submission text file 0001144204-12-035275.txt   23210
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 12912940
SIC: 2836 Biological Products, (No Diagnostic Substances)